Rory P. Remmel

University of Minnesota — United States

Medicine · Health Sciences

51h-index6.9kcitations182works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacological Effects and Toxicity Studies(47), Pharmacogenetics and Drug Metabolism(34), Renal Transplantation Outcomes and Treatments(33), HIV/AIDS drug development and treatment(30), Epilepsy research and treatment(24)

Publications182 total

Gut Microbiome Meta-Transcriptomics Associated with Mycophenolate Mofetil Enterohepatic Recirculation in Kidney Transplant Recipients
American Journal of Transplantation·2025
Simultaneous Prediction of Area Under the Curves of Mycophenolic Acid and Its Metabolites and Enterohepatic Recirculation in Kidney Transplant Recipients
Therapeutic Drug Monitoring·2025
WCN25-1027 BETA-GLUCURONIDASE ACTIVITY OF GUT MICROBIOME AND ENTEROHEPATIC RECIRCULATION OF MYCOPHENOLIC ACID IN KIDNEY TRANSPLANT RECIPIENTS
Kidney International Reports·2025Open Access
Gut Microbiome Signature Associated with Mycophenolate Mofetil Enterohepatic Recirculation
Journal of the American Society of Nephrology·2024
Extreme phenotype sampling and next generation sequencing to identify genetic variants associated with tacrolimus in African American kidney transplant recipients
The Pharmacogenomics Journal·2024· 1 cited
Limited Sampling Strategies Fail to Accurately Predict Mycophenolic Acid Area Under the Curve in Kidney Transplant Recipients and the Impact of Enterohepatic Recirculation
Therapeutic Drug Monitoring·2024· 3 citedOpen Access
Steroid–tacrolimus drug–drug interaction and the effect of CYP3A genotypes
British Journal of Clinical Pharmacology·2024· 4 citedOpen Access
Extreme Phenotype Sampling and Next Generation Sequencing to Identify Genetic Variants Associated with Tacrolimus in African American Kidney Transplant Recipients
2024Open Access
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation
Transplantation·2024· 14 citedOpen Access
Pharmacokinetics and safety of prolonged paracetamol treatment in neonates: An interventional cohort study
British Journal of Clinical Pharmacology·2023· 3 citedOpen Access
Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends
Current Therapeutic Research·2023· 4 citedOpen Access
Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers
Clinical Transplantation·2022· 8 citedOpen Access
Association Between Fecal MicroRNAs and B-Glucuronidase Activity in Kidney Transplant Recipients
Journal of the American Society of Nephrology·2022
Antitubercular Agents
Burger's Medicinal Chemistry and Drug Discovery·2021
Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry
The Journal of Clinical Pharmacology·2021· 13 citedOpen Access
Pharmacogenomics in kidney transplant recipients and potential for integration into practice
Journal of Clinical Pharmacy and Therapeutics·2020· 9 citedOpen Access
PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics
Pharmacogenetics and Genomics·2020· 49 citedOpen Access
Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy
Epilepsia·2019· 112 cited
Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups
American Journal of Transplantation·2019· 54 citedOpen Access
Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies
Transplantation·2019· 24 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Ilo E. Leppik(7), Richard C. Brundage(7), Courtney V. Fletcher(6), Pamala A. Jacobson(6), Frank B. Cerra(5), Upendra A. Argikar(5), Angela K. Birnbaum(5), Scott L. Nyberg(4), Henry J. Mann(4), Dennis R. Weller(4), Wei‐Shou Hu(4), Brenda C. Crews(3), Lawrence J. Marnett(3), Bruce Amiot(3), Brian Burchell(3), Sagar P. Kawle(3), William S. Oetting(3), Roslyn B. Mannon(3), Arthur J. Matas(3), Ajay K. Israni(3)